Rekomendasi Internasional2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With PolyangiitisRekomendasi Internasional2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic PolyangiitisRekomendasi Internasional2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritisRekomendasi Internasional2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19Rekomendasi InternasionalEULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndromeRekomendasi InternasionalEULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 updateRekomendasi Internasional2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseasesRekomendasi Internasional2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseasesRekomendasi InternasionalEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update 1 2 3 4 5
Rekomendasi Internasional2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis
Rekomendasi Internasional2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis
Rekomendasi Internasional2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis
Rekomendasi Internasional2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19
Rekomendasi InternasionalEULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome
Rekomendasi InternasionalEULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update
Rekomendasi Internasional2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases
Rekomendasi Internasional2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases
Rekomendasi InternasionalEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
